The Biomedical Advanced Research and Development Authority within the Department of Health and Human Services is soliciting comments on a
Moderna (Nasdaq: MRNA) has secured a $3.3 billion contract modification from the U.S. Army for additional 200 million filled drug
The departments of Health and Human Services and Defense have earmarked $3.65 billion to buy 100 million additional doses of…
TYSONS CORNER, VA, March 10, 2017 — A subsidiary of CSRA (NYSE: CSRA) has secured orphan drug status from the Food and
TYSONS CORNER, VA, April 11, 2016 — Leidos (NYSE: LDOS) will work with Immunovaccine to develop a vaccine that aims
The Department of Health and Human Services has tapped Emergent BioSolutions to further develop a new anthrax vaccine under a 30-month, $31
The Department of Health and Human Services has awarded Profectus BioSciences an $8.6 million contract to further develop and test
The U.S. government has selected Emergent BioSolutions Inc. (NYSE: EBS) to supply millions of doses of its anthrax vaccine over five
